Last year, the US government announced a plan to reduce HIV incidence by 90% by 2030 through the “90-90-90” target. However, it is not clear how these targets will perform in local epidemics, such as the one in Baltimore City, driven by heterogeneities in HIV transmission and access to care.
We extended the Johns Hopkins HIV economic-epidemic model (JHEEM), a validated compartmental model of HIV transmission, to represent population by sex (male/female), race/ethnicity (black, non-black), age strata (13-24, 25-34, 35-44,45-54, 55+ years old), and CDC risk groups (MSM, injection drug users, heterosexuals), and to include pre-exposure prophylaxis (PrEP). We calibrated the model using 10,000 simulations against CDC-reported new HIV diagnoses and persons living with HIV from 2010-2017 in the Baltimore metropolitan statistical area.
We ran each simulation multiple times from 2020-2030 under a range of potential interventions, targeting HIV testing frequency, proportion of HIV-diagnosed individuals virally suppressed, and proportion of at-risk individuals prescribed and adherent to PrEP. Interventions were targeted at different combinations of high-risk subgroups. For each intervention and target group, we estimated the reduction in total Baltimore incidence that could be achieved between 2020 and 2030. We calculated 95% uncertainty ranges (UR) by weighting simulations according to how well they fit the observed data from 2010-2017.
Continuing testing, suppression, and PrEP at current levels projected a reduction in incidence of 13% [95%UR: 2-35%] from 2020-2030. Interventions targeted to Baltimore’s highest-risk subgroups, black MSM and injection drug users, could achieve reductions of 57% [39-67%] (Table) with yearly testing, 90% suppression among people with diagnosed HIV, and 50% adherence to PrEP, and reductions up to 60% [42-71%] with 75% adherence to PrEP. Achieving close to 90% reduction in incidence from 2020 to 2030 among our tested interventions required expanding these interventions across the entire population.
Ending the HIV epidemic in Baltimore will be challenging, and will require several, broadly targeted interventions to achieve high levels of HIV suppression among diagnosed individuals with HIV as well as high uptake of PrEP and frequent screening across multiple subgroups.